{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:21:17Z","timestamp":1787588477712,"version":"build-2736575974"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-20887-w","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:38:53Z","timestamp":1761125933000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effects of growth hormone and anabolic steroids, in critically ill patients admitted to the intensive care unit: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"15","author":[{"given":"Chris G. H.","family":"Veenker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beynur B.","family":"Redzhebov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne E.","family":"Hoeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas T.","family":"van Eijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel M. R. F.","family":"Struys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"de Hon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico L. U.","family":"van Meeteren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gertrude J.","family":"Nieuwenhuijs-Moeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"20887_CR1","doi-asserted-by":"publisher","first-page":"559789","DOI":"10.3389\/fmed.2020.559789","volume":"7","author":"W Wang","year":"2020","unstructured":"Wang, W., Xu, C., Ma, X., Zhang, X. & Xie, P. Intensive care Unit-Acquired weakness: A review of recent progress with a look toward the future. Front. Med. (Lausanne). 7, 559789. https:\/\/doi.org\/10.3389\/fmed.2020.559789 (2020).","journal-title":"Front. Med. (Lausanne)"},{"issue":"15","key":"20887_CR2","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1001\/jama.2013.278481","volume":"310","author":"ZA Puthucheary","year":"2013","unstructured":"Puthucheary, Z. A. et al. Acute skeletal muscle wasting in critical illness. JAMA 310 (15), 1591\u20131600. https:\/\/doi.org\/10.1001\/jama.2013.278481 (2013).","journal-title":"JAMA"},{"issue":"8","key":"20887_CR3","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1056\/NEJMoa022450","volume":"348","author":"MS Herridge","year":"2003","unstructured":"Herridge, M. S. et al. One-Year outcomes in survivors of the acute respiratory distress syndrome. N Engl. J. Med. 348 (8), 683\u2013693. https:\/\/doi.org\/10.1056\/NEJMoa022450 (2003).","journal-title":"N Engl. J. Med."},{"issue":"14","key":"20887_CR4","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1056\/NEJMoa1011802","volume":"364","author":"MS Herridge","year":"2011","unstructured":"Herridge, M. S. et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl. J. Med. 364 (14), 1293\u20131304. https:\/\/doi.org\/10.1056\/NEJMoa1011802 (2011).","journal-title":"N Engl. J. Med."},{"issue":"17","key":"20887_CR5","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1056\/NEJMra1209390","volume":"370","author":"JP Kress","year":"2014","unstructured":"Kress, J. P. & Hall, J. B. ICU-Acquired weakness and recovery from critical illness. N Engl. J. Med. 370 (17), 1626\u20131635. https:\/\/doi.org\/10.1056\/NEJMra1209390 (2014).","journal-title":"N Engl. J. Med."},{"issue":"3","key":"20887_CR6","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/CCM.0000000000002208","volume":"45","author":"VD Dinglas","year":"2017","unstructured":"Dinglas, V. D. et al. Muscle weakness and 5-Year survival in acute respiratory distress syndrome survivors. Crit. Care Med. 45 (3), 446\u2013453. https:\/\/doi.org\/10.1097\/CCM.0000000000002208 (2017).","journal-title":"Crit. Care Med."},{"key":"20887_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.941097","author":"J Zhang","year":"2022","unstructured":"Zhang, J., Luo, W., Miao, C. & Zhong, J. Hypercatabolism and Anti-catabolic therapies in the persistent Inflammation, Immunosuppression, and catabolism syndrome. Front. Nutr. https:\/\/doi.org\/10.3389\/fnut.2022.941097 (2022).","journal-title":"Front. Nutr."},{"issue":"8","key":"20887_CR8","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2165\/00007256-200434080-00003","volume":"34","author":"F Hartgens","year":"2004","unstructured":"Hartgens, F. & Kuipers, H. Effects of androgenic-anabolic steroids in athletes. Sports Med. 34 (8), 513\u2013554. https:\/\/doi.org\/10.2165\/00007256-200434080-00003 (2004).","journal-title":"Sports Med."},{"issue":"3","key":"20887_CR9","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1468-1293.2006.00358.x","volume":"7","author":"J Gold","year":"2006","unstructured":"Gold, J. et al. Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting. HIV Med. 7 (3), 146\u2013155. https:\/\/doi.org\/10.1111\/j.1468-1293.2006.00358.x (2006).","journal-title":"HIV Med."},{"issue":"4","key":"20887_CR10","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1164\/ajrccm.152.4.7551381","volume":"152","author":"AM Schols","year":"1995","unstructured":"Schols, A. M., Soeters, P. B., Mostert, R., Pluymers, R. J. & Wouters, E. F. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am. J. Respir Crit. Care Med. 152 (4), 1268\u20131274. https:\/\/doi.org\/10.1164\/ajrccm.152.4.7551381 (1995).","journal-title":"Am. J. Respir Crit. Care Med."},{"issue":"5","key":"20887_CR11","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1378\/chest.124.5.1733","volume":"124","author":"EC Creutzberg","year":"2003","unstructured":"Creutzberg, E. C., Wouters, E. F. M., Mostert, R., Pluymers, R. J. & Schols, A. M. W. J. A role for anabolic steroids in the rehabilitation of patients with COPD?*: A Double-Blind, Placebo-Controlled, randomized trial. Chest 124 (5), 1733\u20131742. https:\/\/doi.org\/10.1378\/chest.124.5.1733 (2003).","journal-title":"Chest"},{"issue":"2","key":"20887_CR12","doi-asserted-by":"publisher","first-page":"P014","DOI":"10.1186\/cc1903","volume":"7","author":"J Pikul","year":"2003","unstructured":"Pikul, J. & Sharpe, M. D. Use of anabolic steroid therapy in critically ill ICU patients. Crit. Care. 7 (2), P014. https:\/\/doi.org\/10.1186\/cc1903 (2003).","journal-title":"Crit. Care"},{"issue":"3","key":"20887_CR13","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/bjp.2008.165","volume":"154","author":"AT Kicman","year":"2008","unstructured":"Kicman, A. T. Pharmacology of anabolic steroids. Br. J. Pharmacol. 154 (3), 502\u2013521. https:\/\/doi.org\/10.1038\/bjp.2008.165 (2008).","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"20887_CR14","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/MCC.0000000000000757","volume":"26","author":"PE Wischmeyer","year":"2020","unstructured":"Wischmeyer, P. E. et al. Role of anabolic testosterone agents and structured exercise to promote recovery in ICU survivors. Curr. Opin. Crit. Care. 26 (5), 508\u2013515. https:\/\/doi.org\/10.1097\/MCC.0000000000000757 (2020).","journal-title":"Curr. Opin. Crit. Care"},{"issue":"9","key":"20887_CR15","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1007\/s00134-019-05686-y","volume":"45","author":"E Litton","year":"2019","unstructured":"Litton, E., Latham, P., Inman, J., Luo, J. & Allan, P. Safety and efficacy of erythropoiesis-stimulating agents in critically ill patients admitted to the intensive care unit: a systematic review and meta-analysis. Intensive Care Med. 45 (9), 1190\u20131199. https:\/\/doi.org\/10.1007\/s00134-019-05686-y (2019).","journal-title":"Intensive Care Med."},{"key":"20887_CR16","unstructured":"Redzhebov, B. et al. Effects of Performance Enhancing Drugs on Recovery of Patients\/People During Critical Illness. PROSPERO. https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD42024500492 (2024)."},{"key":"20887_CR17","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"JM Page","year":"2021","unstructured":"Page, J. M. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj 372, n71. https:\/\/doi.org\/10.1136\/bmj.n71 (2021).","journal-title":"Bmj"},{"key":"20887_CR18","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne, J. A. C. et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. Bmj 366, l4898. https:\/\/doi.org\/10.1136\/bmj.l4898 (2019).","journal-title":"Bmj"},{"issue":"12","key":"20887_CR19","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1177\/09622802211047348","volume":"30","author":"S Cai","year":"2021","unstructured":"Cai, S., Zhou, J. & Pan, J. Estimating the sample mean and standard deviation from order statistics and sample size in meta-analysis. Stat. Methods Med. Res. 30 (12), 2701\u20132719. https:\/\/doi.org\/10.1177\/09622802211047348 (2021).","journal-title":"Stat. Methods Med. Res."},{"issue":"11","key":"20887_CR20","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1056\/NEJM199909093411102","volume":"341","author":"J Takala","year":"1999","unstructured":"Takala, J. et al. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl. J. Med. 341 (11), 785\u2013792. https:\/\/doi.org\/10.1056\/NEJM199909093411102 (1999).","journal-title":"N Engl. J. Med."},{"issue":"4","key":"20887_CR21","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/00000658-199810000-00001","volume":"228","author":"RJ Ramirez","year":"1998","unstructured":"Ramirez, R. J., Wolf, S. E., Barrow, R. E. & Herndon, D. N. Growth hormone treatment in pediatric burns: a safe therapeutic approach. Ann. Surg. 228 (4), 439\u2013448. https:\/\/doi.org\/10.1097\/00000658-199810000-00001 (1998).","journal-title":"Ann. Surg."},{"issue":"6","key":"20887_CR22","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/00000658-199212000-00006","volume":"216","author":"HJ Voerman","year":"1992","unstructured":"Voerman, H. J. et al. Effects of Recombinant human growth hormone in patients with severe sepsis. Ann. Surg. 216 (6), 648\u2013655. https:\/\/doi.org\/10.1097\/00000658-199212000-00006 (1992).","journal-title":"Ann. Surg."},{"issue":"3","key":"20887_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0883-9441(94)90010-8","volume":"9","author":"BJ Voerman","year":"1994","unstructured":"Voerman, B. J. et al. Effects of human growth hormone on fuel utilization and mineral balance in critically ill patients on full intravenous nutritional support. J. Crit. Care. 9 (3), 143\u2013150. https:\/\/doi.org\/10.1016\/0883-9441(94)90010-8 (1994).","journal-title":"J. Crit. Care"},{"issue":"1","key":"20887_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000222940","volume":"21","author":"J Tacke","year":"1994","unstructured":"Tacke, J., Bolder, U. & L\u00f6hlein, D. Improved cumulated nitrogen balance after administration of Recombinant human growth hormone in patients undergoing Gastrointestinal surgery. Infusionsther Transfusionsmed. 21 (1), 24\u201329. https:\/\/doi.org\/10.1159\/000222940 (1994).","journal-title":"Infusionsther Transfusionsmed"},{"issue":"2","key":"20887_CR25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00005373-199508000-00018","volume":"39","author":"SR Petersen","year":"1995","unstructured":"Petersen, S. R., Jeevanandam, M. & Holaday, N. J. Adjuvant Recombinant human growth hormone stimulates insulin-like growth factor binding protein-3 secretion in critically ill trauma patients. J. Trauma. 39 (2), 295\u2013300. https:\/\/doi.org\/10.1097\/00005373-199508000-00018 (1995).","journal-title":"J. Trauma."},{"issue":"4","key":"20887_CR26","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/00003246-199504000-00014","volume":"23","author":"BJ Voerman","year":"1995","unstructured":"Voerman, B. J. et al. Effects of human growth hormone in critically ill nonseptic patients: results from a prospective, randomized, placebo-controlled trial. Crit. Care Med. 23 (4), 665\u2013673. https:\/\/doi.org\/10.1097\/00003246-199504000-00014 (1995).","journal-title":"Crit. Care Med."},{"issue":"1","key":"20887_CR27","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/00005373-199501000-00031","volume":"38","author":"E Roth","year":"1995","unstructured":"Roth, E. et al. Resistance of nitrogen metabolism to growth hormone treatment in the early phase after injury of patients with multiple injuries. J. Trauma. 38 (1), 136\u2013141. https:\/\/doi.org\/10.1097\/00005373-199501000-00031 (1995).","journal-title":"J. Trauma."},{"issue":"3","key":"20887_CR28","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/00003246-199603000-00008","volume":"24","author":"C Pichard","year":"1996","unstructured":"Pichard, C. et al. Lack of effects of Recombinant growth hormone on muscle function in patients requiring prolonged mechanical ventilation: A prospective, randomized, controlled study. Crit. Care Med. 24 (3), 403\u2013413. https:\/\/doi.org\/10.1097\/00003246-199603000-00008 (1996).","journal-title":"Crit. Care Med."},{"issue":"4","key":"20887_CR29","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/00000658-200004000-00018","volume":"231","author":"L Gamrin","year":"2000","unstructured":"Gamrin, L. et al. Protein-Sparing effect in skeletal muscle of growth hormone treatment in critically ill patients. Ann. Surg. 231 (4), 577\u2013586. https:\/\/doi.org\/10.1097\/00000658-200004000-00018 (2000).","journal-title":"Ann. Surg."},{"issue":"11","key":"20887_CR30","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1592\/phco.20.17.1328.34889","volume":"20","author":"JM Gervasio","year":"2000","unstructured":"Gervasio, J. M. et al. Oxandrolone in trauma patients. Pharmacotherapy 20 (11), 1328\u20131334. https:\/\/doi.org\/10.1592\/phco.20.17.1328.34889 (2000).","journal-title":"Pharmacotherapy"},{"issue":"2","key":"20887_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/s0899-9007(01)00769-9","volume":"18","author":"AM Umpleby","year":"2002","unstructured":"Umpleby, A. M., Carroll, P. V., Russell-Jones, D. L., Treacher, D. F. & Jackson, N. C. Glutamine supplementation and GH\/IGF-I treatment in critically ill patients: effects on glutamine metabolism and protein balance. Nutrition 18 (2), 127\u2013129. https:\/\/doi.org\/10.1016\/s0899-9007(01)00769-9 (2002).","journal-title":"Nutrition"},{"issue":"1","key":"20887_CR32","doi-asserted-by":"publisher","first-page":"E151","DOI":"10.1152\/ajpendo.00122.2003","volume":"286","author":"PV Carroll","year":"2004","unstructured":"Carroll, P. V. et al. Combined growth hormone\/insulin-like growth factor I in addition to glutamine-supplemented TPN results in net protein anabolism in critical illness. Am. J. Physiol. Endocrinol. Metab. 286 (1), E151\u2013E157. https:\/\/doi.org\/10.1152\/ajpendo.00122.2003 (2004).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"3","key":"20887_CR33","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/01.sla.0000137131.22608.e2","volume":"240","author":"EM Bulger","year":"2004","unstructured":"Bulger, E. M., Jurkovich, G. J., Farver, C. L., Klotz, P. & Maier, R. V. Oxandrolone does not improve outcome of ventilator dependent surgical patients. Ann. Surg. 240 (3), 472\u2013478. https:\/\/doi.org\/10.1097\/01.sla.0000137131.22608.e2 (2004).","journal-title":"Ann. Surg."},{"issue":"2","key":"20887_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/01.BCR.0000202620.55751.4F","volume":"27","author":"SE Wolf","year":"2006","unstructured":"Wolf, S. E. et al. Effects of Oxandrolone on outcome measures in the severely burned: A multicenter prospective randomized Double-Blind trial. J. Burn Care Res. 27 (2), 131\u2013139. https:\/\/doi.org\/10.1097\/01.BCR.0000202620.55751.4F (2006).","journal-title":"J. Burn Care Res."},{"issue":"3","key":"20887_CR35","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11596-007-0321-9","volume":"27","author":"Y Guo","year":"2007","unstructured":"Guo, Y., Bai, X., Lin, G. & Tang, Z. Altered nutrition state in the severe multiple trauma patients undergoing adjuvant Recombinant human growth hormone nutritional support therapy. J. Huazhong Univ. Sci. Technolog Med. Sci. 27 (3), 299\u2013302. https:\/\/doi.org\/10.1007\/s11596-007-0321-9 (2007).","journal-title":"J. Huazhong Univ. Sci. Technolog Med. Sci."},{"issue":"3","key":"20887_CR36","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/SLA.0b013e318146980e","volume":"246","author":"MG Jeschke","year":"2007","unstructured":"Jeschke, M. G. et al. The effect of Oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn. Ann. Surg. 246 (3), 351\u2013360. https:\/\/doi.org\/10.1097\/SLA.0b013e318146980e (2007).","journal-title":"Ann. Surg."},{"issue":"2","key":"20887_CR37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/PCC.0b013e318166d414","volume":"9","author":"MG Jeschke","year":"2008","unstructured":"Jeschke, M. G. et al. Combination of Recombinant human growth hormone and propranolol decreases hypermetabolism and inflammation in severely burned children. Pediatr. Crit. Care Med. 9 (2), 209\u2013216. https:\/\/doi.org\/10.1097\/PCC.0b013e318166d414 (2008).","journal-title":"Pediatr. Crit. Care Med."},{"issue":"6","key":"20887_CR38","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1097\/CCM.0b013e318174d499","volume":"36","author":"F Du\u0161ka","year":"2008","unstructured":"Du\u0161ka, F. et al. Frequent intravenous pulses of growth hormone together with glutamine supplementation in prolonged critical illness after multiple trauma: effects on nitrogen balance, insulin resistance, and substrate oxidation. Crit. Care Med. 36 (6), 1707\u20131713. https:\/\/doi.org\/10.1097\/CCM.0b013e318174d499 (2008).","journal-title":"Crit. Care Med."},{"issue":"4","key":"20887_CR39","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jamcollsurg.2011.12.038","volume":"214","author":"LJ Porro","year":"2012","unstructured":"Porro, L. J. et al. Five-Year outcomes after Oxandrolone administration in severely burned children: A randomized clinical trial of safety and efficacy. J. Am. Coll. Surg. 214 (4), 489\u2013502. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2011.12.038 (2012).","journal-title":"J. Am. Coll. Surg."},{"issue":"2","key":"20887_CR40","doi-asserted-by":"publisher","first-page":"175","DOI":"10.35975\/apic.v26i2.1833","volume":"26","author":"EH Shaker","year":"2022","unstructured":"Shaker, E. H. & Kamel, M. A. Role of Recombinant human growth hormone in weaning of prolonged ventilation after major abdominal cancer surgeries; open-label, placebo-controlled, randomized trial. Anaesth. Pain Intensive Care. 26 (2), 175\u2013181. https:\/\/doi.org\/10.35975\/apic.v26i2.1833 (2022).","journal-title":"Anaesth. Pain Intensive Care"},{"issue":"3","key":"20887_CR41","doi-asserted-by":"publisher","first-page":"295","DOI":"10.4266\/acc.2021.01767","volume":"37","author":"MH Anstey","year":"2022","unstructured":"Anstey, M. H. et al. Muscle growth and anabolism in intensive care survivors (GAINS) trial: a pilot randomised controlled trial. Acute Crit. Care. 37 (3), 295\u2013302. https:\/\/doi.org\/10.4266\/acc.2021.01767 (2022).","journal-title":"Acute Crit. Care"},{"key":"20887_CR42","doi-asserted-by":"publisher","DOI":"10.18502\/aacc.v9i3.13116","author":"H Abdollahi","year":"2023","unstructured":"Abdollahi, H., Yousefi, A. & Ghadami, L. Effects of nandrolone on outcomes and metabolic response in critically ill patients. Arch. Anesth. Crit. Care. https:\/\/doi.org\/10.18502\/aacc.v9i3.13116 (2023).","journal-title":"Arch. Anesth. Crit. Care"},{"issue":"2","key":"20887_CR43","doi-asserted-by":"publisher","first-page":"e1230","DOI":"10.1002\/cl2.1230","volume":"18","author":"NR Haddaway","year":"2022","unstructured":"Haddaway, N. R., Page, M. J., Pritchard, C. C. & McGuinness, L. A. PRISMA2020: an R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and open synthesis. Campbell Syst. Rev. 18 (2), e1230. https:\/\/doi.org\/10.1002\/cl2.1230 (2022).","journal-title":"Campbell Syst. Rev."},{"issue":"4","key":"20887_CR44","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.clnu.2011.12.006","volume":"31","author":"MJ Allingstrup","year":"2012","unstructured":"Allingstrup, M. J. et al. Provision of protein and energy in relation to measured requirements in intensive care patients. Clin. Nutr. 31 (4), 462\u2013468. https:\/\/doi.org\/10.1016\/j.clnu.2011.12.006 (2012).","journal-title":"Clin. Nutr."},{"issue":"11\u201312","key":"20887_CR45","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/s0899-9007(03)00175-8","volume":"19","author":"CD Scheinkestel","year":"2003","unstructured":"Scheinkestel, C. D. et al. Prospective randomized trial to assess caloric and protein needs of critically Ill, anuric, ventilated patients requiring continuous renal replacement therapy. Nutrition 19 (11\u201312), 909\u2013916. https:\/\/doi.org\/10.1016\/s0899-9007(03)00175-8 (2003).","journal-title":"Nutrition"},{"issue":"9","key":"20887_CR46","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.clnu.2023.07.011","volume":"42","author":"P Singer","year":"2023","unstructured":"Singer, P. et al. ESPEN practical and partially revised guideline: clinical nutrition in the intensive care unit. Clin. Nutr. 42 (9), 1671\u20131689. https:\/\/doi.org\/10.1016\/j.clnu.2023.07.011 (2023).","journal-title":"Clin. Nutr."},{"issue":"6","key":"20887_CR47","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/s0002-9610(96)00033-5","volume":"171","author":"JB Knox","year":"1996","unstructured":"Knox, J. B., Wilmore, D. W., Demling, R. H., Sarraf, P. & Santos, A. A. Use of growth hormone for postoperative respiratory failure. Am. J. Surg. 171 (6), 576\u2013580. https:\/\/doi.org\/10.1016\/s0002-9610(96)00033-5 (1996).","journal-title":"Am. J. Surg."},{"issue":"8","key":"20887_CR48","doi-asserted-by":"publisher","first-page":"bqac088","DOI":"10.1210\/endocr\/bqac088","volume":"163","author":"H Zhengxiang","year":"2022","unstructured":"Zhengxiang, H., Lan, X., Yin, X. & Chen, C. The modulatory role of growth hormone in inflammation and macrophage activation. Endocrinology 163 (8), bqac088. https:\/\/doi.org\/10.1210\/endocr\/bqac088 (2022).","journal-title":"Endocrinology"},{"issue":"7","key":"20887_CR49","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1210\/jcem.82.7.4103","volume":"82","author":"AA Toogood","year":"1997","unstructured":"Toogood, A. A. et al. Preservation of growth hormone pulsatility despite pituitary pathology, surgery, and irradiation. J. Clin. Endocrinol. Metab. 82 (7), 2215\u20132221. https:\/\/doi.org\/10.1210\/jcem.82.7.4103 (1997).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"20887_CR50","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1530\/EJE-08-0786","volume":"160","author":"P Schuetz","year":"2009","unstructured":"Schuetz, P., M\u00fcller, B., Nusbaumer, C., Wieland, M. & Christ-Crain, M. Circulating levels of GH predict mortality and complement prognostic scores in critically ill medical patients. Eur. J. Endocrinol. 160 (2), 157\u2013163. https:\/\/doi.org\/10.1530\/EJE-08-0786 (2009).","journal-title":"Eur. J. Endocrinol."},{"issue":"1\u20133","key":"20887_CR51","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000183766","volume":"40","author":"ML Hartman","year":"1993","unstructured":"Hartman, M. L., Veldhuis, J. D. & Thorner, M. O. Normal control of growth hormone secretion. Horm. Res. 40 (1\u20133), 37\u201347. https:\/\/doi.org\/10.1159\/000183766 (1993).","journal-title":"Horm. Res."},{"key":"20887_CR52","doi-asserted-by":"publisher","first-page":"113670","DOI":"10.1016\/j.ygcen.2020.113670","volume":"302","author":"X Lyu","year":"2021","unstructured":"Lyu, X., Wang, G., Pi, Z. & Wu, L. Circadian clock disruption attenuated growth hormone(GH)-mediated signalling. Gen. Comp. Endocrinol. 302, 113670. https:\/\/doi.org\/10.1016\/j.ygcen.2020.113670 (2021).","journal-title":"Gen. Comp. Endocrinol."},{"key":"20887_CR53","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.nut.2016.06.013","volume":"33","author":"MD DeBoer","year":"2017","unstructured":"DeBoer, M. D. et al. Systemic inflammation, growth factors, and linear growth in the setting of infection and malnutrition. Nutrition 33, 248\u2013. https:\/\/doi.org\/10.1016\/j.nut.2016.06.013 (2017).","journal-title":"Nutrition"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20887-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20887-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20887-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:38:54Z","timestamp":1761125934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20887-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["20887"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-20887-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"30 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36856"}}